Ihab Girgis
CSL (United States)(US)ATP Clinical Research (United States)(US)
Publications by Year
Research Areas
Fluid Dynamics and Turbulent Flows, Gas Dynamics and Kinetic Theory, Computational Fluid Dynamics and Aerodynamics, Plasma and Flow Control in Aerodynamics, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis(2018)409 cited
- → Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*(2019)232 cited
- → Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab(2019)184 cited
- → Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors(2021)122 cited
- → Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non‐valvular atrial fibrillation: Results from ROCKET AF(2014)107 cited
- → Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiologic procedures(1999)80 cited